Gremlin-1 has been found to be involved in adipose tissue dysfunction and insulin resistance, antagonizes insulin action and is overexpressed in type 2 diabetes, obesity, non-alcoholic fatty liver disease (NAFLD) and in polycystic ovarian syndrome (PCOS) [4]. This evidence concerns the gene GREM1 and polycystic ovary syndrome.